|
C
|
CANCER RESEARCH TECHNOLOGY LIMITED ActiveScientific & Education |
Financial statements of CANCER RESEARCH TECHNOLOGY LIMITED
According to CANCER RESEARCH TECHNOLOGY LIMITED latest financial report submitted on 2022-03-31, the company has a Turnover of £92M, Gross-Profit of £47M while the Cash is £3M. Compared with the previous year, the company reported a Turnover increase of 0.91%, which is an equivalent of -839000. At the same time, the Gross-Profit went up by 4.25%, or by -1980000.
Turnover 2022
£ 92.2 million
-
Consolidated A/cs
N
-
Reporting period
12
-
Working Capital
£ 10.7 million
-
Profit after Tax
£ 38.6 million
CANCER RESEARCH TECHNOLOGY LIMITED Business Credit Report
A Business Credit Report for CANCER RESEARCH TECHNOLOGY LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for CANCER RESEARCH TECHNOLOGY LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.
CANCER RESEARCH TECHNOLOGY LIMITED
CANCER RESEARCH TECHNOLOGY LIMITED Directors and key executives
View all employeesCANCER RESEARCH TECHNOLOGY LIMITED currently employs 180 people. Compared with the previous year, the company has reported a staff increase of 8%, which is an equivalent of 14 employees. In order to view contact information, including emails and phone numbers for all the employees working at CANCER RESEARCH TECHNOLOGY LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.
Total Employee Count
Total employees
180
108%
1y growth
98%
2y growth
Management Level
Middle
| Employee | Job Title | Phone | Country | |
|---|---|---|---|---|
| Peter Chambre | Director |
*****@cancertechnology.co.uk
|
- | GB |
| Parker Moss | Director |
-
|
- | GB |
| Anna Jenkins | Director |
-
|
- | GB |
| Parker Moss | Director |
-
|
- | GB |
| Christoph Lengauer | Director |
-
|
- | GB |
Get in touch with 12 of contacts working at CANCER RESEARCH TECHNOLOGY LIMITED
Upgrade to subscriptionCANCER RESEARCH TECHNOLOGY LIMITED Ownership and Group Structure
View full group structureCANCER RESEARCH TECHNOLOGY LIMITED is a subsidiary of CANCER RES******** which is a holding company, with the following registration number 01626049. The holding group consists of a total of 8 companies, including CANCER RES********, CANCER RESEARCH UK****************, CANCER RESEARCH UK PEN********************, BEATSON INSTITUTE F******************, BEATSON TECHNO************.
CANCER RESEARCH TECHNOLOGY LIMITED competitors:
View all competitorsTop 5 similar companies of CANCER RESEARCH TECHNOLOGY LIMITED are SYGNATURE DISCOVERY LIMITED, NONACUS LIMITED, CHARLES RIVER U.K. LIMITED, UK BIOCENTRE LIMITED. View and export all the competitor list of CANCER RESEARCH TECHNOLOGY LIMITED by upgrading your account here.
SYGNATURE DISCOVERY LIMITED
NONACUS LIMITED
CHARLES RIVER U.K. LIMITED
UK BIOCENTRE LIMITED
CANCER RESEARCH TECHNOLOGY LIMITED news & activities:
View full activityTurnover
CANCER RESEARCH TECHNOLOGY LIMITED has submitted new account statements and has reported a turnover of £92M, a 0.91% decrease year-over-year.
uk.globaldatabase.com
2021-03-31
EBITDA
The CANCER RESEARCH TECHNOLOGY LIMITED-based company said the adjusted EBITDA is now £33M, compared with the previous year of 32.7 million.
uk.globaldatabase.com
2021-03-31
Employees
CANCER RESEARCH TECHNOLOGY LIMITED number of employees has increased by 8% compared with previous year and now represents a total number of 180.
uk.globaldatabase.com
2021-03-31
Frequently Asked Questions regarding CANCER RESEARCH TECHNOLOGY LIMITED
Where is CANCER RESEARCH TECHNOLOGY LIMITED registered office?
CANCER RESEARCH TECHNOLOGY LIMITED is located at 2 Redman Place, United Kingdom.
How can I contact CANCER RESEARCH TECHNOLOGY LIMITED?
You can call CANCER RESEARCH TECHNOLOGY LIMITED at the following number +442034******
What is the website of CANCER RESEARCH TECHNOLOGY LIMITED?
CANCER RESEARCH TECHNOLOGY LIMITED website is http://www.cancertechnology.co.uk
How many people work at CANCER RESEARCH TECHNOLOGY LIMITED?
According to the latest account statement, there are currently 180 of employees working for CANCER RESEARCH TECHNOLOGY LIMITED.
How much revenue does CANCER RESEARCH TECHNOLOGY LIMITED make?
Based on the latest financial accounts submitted on 2022-03-31, the company made £92M for 2022, which went up by 0.91%.
What is CANCER RESEARCH TECHNOLOGY LIMITED EBITDA?
For 2022, CANCER RESEARCH TECHNOLOGY LIMITED has reported an EBITDA of £33M, which went down by -0.09% compared to previous year.
What is the Business Credit Score of CANCER RESEARCH TECHNOLOGY LIMITED and how reliable is the company?
In order to check the business credit score of CANCER RESEARCH TECHNOLOGY LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.
Does CANCER RESEARCH TECHNOLOGY LIMITED pay their invoices on time?
By requesting a Business Credit Report for CANCER RESEARCH TECHNOLOGY LIMITED, you will be able to gain more insights about the CANCER RESEARCH TECHNOLOGY LIMITED payment trends.
Who is the Ultimate Parent of the CANCER RESEARCH TECHNOLOGY LIMITED?
Information about the ultimate beneficial ownership CANCER RES******** of CANCER RESEARCH TECHNOLOGY LIMITED is available when you order a business credit report.
Search for International Credit Report
One report
-
Credit Rating and Limit Recomendations
-
5 years of financial statements
-
Directors and shareholders
-
Court Judgements
-
Global Group Structure
-
Trade Payment
Unlimited reports
-
Everything include in one report, plus
-
Unlimited credit reports download
-
Unlimited users
-
API access
-
CRM Integration
-
Dedicated account manager
Select your package
|
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
One report
-
Credit Rating and Limit Recomendations
-
5 years of financial statements
-
Directors and shareholders
-
Court Judgements
-
Global Group Structure
-
Trade Payment
Unlimited reports
-
Everything include in one report, plus
-
Unlimited credit reports download
-
Unlimited users
-
API access
-
CRM Integration
-
Dedicated account manager
Select your package
